argenx SE (ARGX)
NASDAQ: ARGX · IEX Real-Time Price · USD
471.32
+4.76 (1.02%)
At close: Jul 19, 2024, 4:00 PM
474.01
+2.69 (0.57%)
Pre-market: Jul 22, 2024, 6:16 AM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $28.01 billion as of July 22, 2024. Its market cap has increased by 30.98% in one year.
Market Cap
28.01B
Enterprise Value
24.57B
1-Year Change
30.98%
Ranking
Category
Stock Price
$471.32
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $28.01B, an increase of 4,432.53%. That is a compound annual growth rate of 70.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 27.90B | 31.06% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biogen | 32.96B |
| Alnylam Pharmaceuticals | 30.08B |
| ResMed | 29.84B |
| Veeva Systems | 29.62B |
| Mettler-Toledo International | 28.71B |
| ICON PLC | 27.26B |
| Koninklijke Philips | 24.13B |
| West Pharmaceutical Services | 23.16B |